ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,718Medicare Part D Prescriptions Filled, Including Refills

Rank: 309 out of 955

$412K Total Retail Price of All Prescriptions

Rank: 369 out of 955

500 Patients Receiving at Least One Drug in Part D
69% Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Arkansas
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 500 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $47 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
LEVOTHYROXINE SODIUM 469 403 66 1 3
OMEPRAZOLE 377 313 75 2 5
GABAPENTIN 326 199 87 3 10
METFORMIN HCL 320 253 51 4 8
SIMVASTATIN 311 276 49 5 4
AMLODIPINE BESYLATE 222 140 42 6 6
LISINOPRIL 218 173 41 7 2
CITALOPRAM HBR 208 163 40 8 16
ATENOLOL 187 145 29 9 21
ATORVASTATIN CALCIUM 175 156 27 10 13
FUROSEMIDE 140 107 36 11 7
POTASSIUM CHLORIDE 135 97 29 12 9
LOSARTAN POTASSIUM 135 109 21 12 28
METOPROLOL SUCCINATE 132 118 21 14 23
HYDROCHLOROTHIAZIDE 124 100 24 15 14
DICLOFENAC SODIUM 123 93 57 16 95
METOPROLOL TARTRATE 120 115* 23 17 12
ISOSORBIDE MONONITRATE ER 117 99 15 18 55
CARVEDILOL 110 83 23 19 27
MELOXICAM 109 86 31 20 15
AMOX TR-POTASSIUM CLAVULANATE 106 78 88 21 123
PRAVASTATIN SODIUM 105 63 17 22 11
CIPROFLOXACIN HCL 104 79 75 23 58
CLOPIDOGREL 101 96* 17 24 18
CRESTOR 93 77 19 25 49
LISINOPRIL-HYDROCHLOROTHIAZIDE 92 46 18 26 22
METFORMIN HCL ER 90 60 14 27 66
BISOPROLOL-HYDROCHLOROTHIAZIDE 86 64 11 28 130
NEXIUM 85 23 17 29 25
ZOLPIDEM TARTRATE 83 47 15 30 24
WARFARIN SODIUM 83 45 14 30 19
AMITRIPTYLINE HCL 82 57 14 R 32 45
AZITHROMYCIN 81 42 68 33 41
FLUTICASONE PROPIONATE 77 60 51 34 38
PAROXETINE HCL 75 64 12 35 68
TRAZODONE HCL 75 32 19 35 30
ALLOPURINOL 73 46 18 37 34
TRAMADOL HCL 70 65* 18 38 17
LOVASTATIN 65 <11 <11 39 52
AMLODIPINE BESYLATE-BENAZEPRIL 61 <11 <11 40 76
PROAIR HFA 60 32 23 41 36
LOSARTAN-HYDROCHLOROTHIAZIDE 59 <11 <11 42 53
TAMSULOSIN HCL 57 52* 16 43 29
FLUOXETINE HCL 56 <11 <11 44 48
GLIPIZIDE 53 <11 <11 45 50
GLYBURIDE 52 <11 <11 R 46 118
TRAMADOL HCL-ACETAMINOPHEN 50 45* 18 47 209
PANTOPRAZOLE SODIUM 50 38 12 47 42
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.